Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction
about
Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhoodOmega-3 fatty acids for intermittent claudicationEpidural therapy for the treatment of severe pre-eclampsia in non labouring womenMagnesium sulphate versus phenytoin for eclampsiaMagnesium sulphate versus lytic cocktail for eclampsiaMagnesium sulphate versus diazepam for eclampsiaInterventions for treating pre-eclampsia and its consequences: generic protocolOmega-3 fatty acids for intermittent claudicationDocosahexaenoic Acid and Cognition throughout the LifespanBenefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactationPolyunsaturated Fatty Acid (PUFA) Status in Pregnant Women: Associations with Sleep Quality, Inflammation, and Length of GestationExposure to organochlorines and mercury through fish and marine mammal consumption: associations with growth and duration of gestation among Inuit newbornsGlobal report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept.Abnormal neurological responses in young adult offspring caused by excess omega-3 fatty acid (fish oil) consumption by the mother during pregnancy and lactationAntenatal interventions to reduce preterm birth: an overview of Cochrane Systematic Reviews.The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient careCommensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical TrialsThe Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial.Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trialMaternal micronutrient status and preterm versus term birth for black and white US women.Maternal vitamin D status and the risk of mild and severe preeclampsia.Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy.Pre-eclampsia, eclampsia, and hypertensionDHA supplementation and pregnancy outcomes.Do in utero events contribute to current health disparities in reproductive medicine?The critically ill obstetric patient - Recent concepts.Mixing nulliparous and multiparous women in randomised controlled trials of preeclampsia prevention is debatable: evidence from a systematic review.Relations of plasma polyunsaturated Fatty acids with blood pressures during the 26th and 28th week of gestation in women of Chinese, Malay, and Indian ethnicityLong chain polyunsaturated fatty acid supplementation in infancy increases length- and weight-for-age but not BMI to 6 years when controlling for effects of maternal smoking.Maternal omega-3 supplementation increases fat mass in male and female rat offspringFish Oil Supplementation does not Reduce Risks of Gestational Diabetes Mellitus, Pregnancy-Induced Hypertension, or Pre-Eclampsia: A Meta-Analysis of Randomized Controlled TrialsAssociations between gene polymorphisms in fatty acid metabolism pathway and preterm delivery in a US urban black population.Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence.The fetal origins of the metabolic syndrome: can we intervene?Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.Body weight affects ω-3 polyunsaturated fatty acid (PUFA) accumulation in youth following supplementation in post-hoc analyses of a randomized controlled trial.Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study.Vitamin D status in early pregnancy and risk of preeclampsia.
P2860
Q24186353-813EB632-7614-4192-B755-F8261E7BD943Q24201333-0C03C043-40C4-4DA1-8786-FD82C00004C9Q24203987-FAF28273-2E60-40B8-AB36-87B1D688E716Q24234534-40A90601-D9E5-4247-AE58-747671ABD0EFQ24235322-68FCFA00-88FF-4254-8F6E-EDAB3E5172B4Q24235678-0041040C-ABCB-4464-93F9-A635BC1A8413Q24240658-286B6B1B-FEB0-4E0B-8AA1-19DA31B050B1Q24243172-D254CFF5-FB6B-4223-AAFD-46187803AEF3Q26768442-F43EEFEE-8580-4311-A9D0-969443F6A935Q26996382-B57B62E5-1D97-4148-9A31-B75347BE9A3AQ28386437-250E280E-ADF5-48AA-B9B4-C5D486C4E85DQ28397151-CF2AA05B-E81B-443B-9904-89F585BA5294Q30227236-594653F2-B77D-4CDF-9EFE-8333BC5C41C0Q30383425-52157A22-F8AC-4FA4-A869-EA52CB3C3352Q30484422-BB899472-3D7E-4E44-B831-1177697B8087Q30578125-F76D72A0-0C60-4A93-9D73-BC912B577A3BQ30973898-C5E3A164-4F99-4E9F-A5B9-265E7AFCC42DQ31110838-8329AC85-57BD-49D6-8FE4-5A0684792E1BQ33566821-94B76860-F74A-4EFC-A920-2DF16059EC85Q33618715-20DFF0D9-3DB9-47CF-B65C-5B44870D3024Q33714239-2CC6DE39-3D95-4CA9-BDFD-EDC033514BB7Q33740987-89590200-17E8-4F5D-A9CC-24B1C6B32C56Q33850028-C53AECA1-3783-4DE4-BD4F-C282512E7CDBQ33875780-974AD797-8FA3-4331-ACF8-CE4F35333931Q33947390-2B63E981-AD4A-4D13-8657-5DA1194EA45CQ34035656-CE39BAF9-98DE-46DD-B59F-AD81B556012AQ34124941-E73B5161-5207-4265-9999-C3F5EE6EDF7BQ34349590-38A04F7B-BF51-42DF-B58E-5EC155D7F69CQ34795816-8DDCF514-EB75-4240-A540-F09BFA48DCBCQ35571318-8E68CC64-F941-463A-87C3-9E29A1C43E50Q35648737-C5E1B284-99D4-4D0A-BEE5-0D9BC4E6EAF1Q35711266-8E64B932-5F37-4B55-98D8-02F51101295DQ35740759-0EA33F72-DA15-480C-8546-B14CCB266D36Q35991776-36847CDD-2641-417C-9C9E-76E450F326E8Q36220958-A371B112-AEEC-4A9D-B32E-210C100478F8Q36277582-A35AAC88-6519-46C9-923E-DAB97310712CQ36279075-FC996F46-0AC2-4937-8E37-9F515DA24B71Q36335742-14FBEC1C-906E-487E-8F93-FE281BDED27DQ37236175-757CA212-9919-4382-B7F3-D0E4990EACCAQ37256236-5138ECF6-19A3-4D23-BD0E-2FBEC6E3840F
P2860
Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Marine oil, and other prostagl ...... ntrauterine growth restriction
@ast
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en-gb
Marine oil, and other prostagl ...... ntrauterine growth restriction
@nl
type
label
Marine oil, and other prostagl ...... ntrauterine growth restriction
@ast
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en-gb
Marine oil, and other prostagl ...... ntrauterine growth restriction
@nl
prefLabel
Marine oil, and other prostagl ...... ntrauterine growth restriction
@ast
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en-gb
Marine oil, and other prostagl ...... ntrauterine growth restriction
@nl
P2860
P3181
P1476
Marine oil, and other prostagl ...... ntrauterine growth restriction
@en
P2093
Sjurdur F Olsen
P2860
P3181
P356
10.1002/14651858.CD003402.PUB2
P577
2006-07-19T00:00:00Z